These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 495259)

  • 1. Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectations.
    Meyer HM
    Adv Exp Med Biol; 1979; 118():1-5. PubMed ID: 495259
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell substrates for biologicals other than vaccines. Introductory remarks.
    Vilcek J
    Adv Exp Med Biol; 1979; 118():115-27. PubMed ID: 495261
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell substrates. Their use in the production of vaccines and other biologicals. Benefit-risk assessment.
    Dull HB
    Adv Exp Med Biol; 1979; 118():187-93. PubMed ID: 495265
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell substrates. Their use in the production of vaccines and other biologicals.
    Adv Exp Med Biol; 1979; 118():1-220. PubMed ID: 40404
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular immortalization process: relevant issues for the generation of cell substrates for production of vaccines and other biologicals.
    Sedivy JM
    Dev Biol (Basel); 2001; 106():479-86; discussion 486-8, 501-11. PubMed ID: 11761263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transforming activity of DNA and proteins in continuous cell cultures and the safety of biologicals].
    Bektimitov TA
    Vopr Virusol; 1987; 32(5):519-24. PubMed ID: 3324478
    [No Abstract]   [Full Text] [Related]  

  • 8. Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologics.
    Petricciani JC; Salk PL; Salk J; Noguchi PD
    Dev Biol Stand; 1981; 50():15-25. PubMed ID: 7341291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory philosophy and acceptability of cells for the production of biologicals.
    Petricciani JC
    Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 12. Symposium on Continuous Cell Lines as Substrates for Biologicals. Arlington, Virginia, USA (Washington, D.C.), May 26-29, 1988. Proceedings.
    Dev Biol Stand; 1989; 70():1-304. PubMed ID: 2759343
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major achievements of biological products in China.
    Li H
    Chin Med J (Engl); 2000 Oct; 113(10):942-7. PubMed ID: 11775846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings of the Joint ESACT -- IABS meeting on the use of heteroploid and other cell substrates for the production of biologicals. Heidelberg (F.R. Germany) 18-22 May, 1981.
    Dev Biol Stand; 1981; 50():1-398. PubMed ID: 7341286
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal cell substrates: back to the future.
    Petricciani J
    PDA J Pharm Sci Technol; 2010; 64(5):375-8. PubMed ID: 21502040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons alpha and beta as cellular regulatory molecules.
    Tamm I; Lin SL; Pfeffer LM; Sehgal PB
    Interferon; 1987; 9():13-74. PubMed ID: 3316040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.